Combined Therapy in Dyslipidemia and Hyperglicemia of Diabetes Mellitus Type II

Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s5220
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Changes in Erythrocyte Membrane in Type-Ii Diabetes Mellitus With and Without Dyslipidemia

Journal of Diabetes & Metabolism
2011English

Dyslipidemia Prevalence, Atherogenicity and Type 2 Diabetes Mellitus

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2020English

Combined Therapy of Diabetes Mellitus

BMJ
1963English

Prevalence and Phenotypic Distribution of Dyslipidemia in Type 1 Diabetes Mellitus

Archives of Internal Medicine
2000English

Type–ii Diabetes Mellitus;

The Professional Medical Journal
2019English

HbA1c as Screening Biomarker of Dyslipidemia in Type 2 Diabetes Mellitus Patients

International Journal of Advances in Medicine
2018English

Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross Sectional Study

Journal of Medical Science And clinical Research
2019English

Pathogenesis and Pathological States of Type II Diabetes Mellitus

Journal for the Integrated Study of Dietary Habits
2000English

Combined Atherosclerotic Lesions in Patients With Type 2 Diabetes Mellitus

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy